Prudential Financial’s TG Therapeutics TGTX Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $6.81M | Buy |
189,315
+9,925
| +6% | +$357K | 0.01% | 771 |
|
2025
Q1 | $7.07M | Buy |
179,390
+10,815
| +6% | +$426K | 0.01% | 711 |
|
2024
Q4 | $5.07M | Sell |
168,575
-136,762
| -45% | -$4.12M | 0.01% | 871 |
|
2024
Q3 | $7.14M | Buy |
305,337
+219,748
| +257% | +$5.14M | 0.01% | 819 |
|
2024
Q2 | $1.52M | Buy |
85,589
+75,035
| +711% | +$1.33M | ﹤0.01% | 1580 |
|
2024
Q1 | $161K | Sell |
10,554
-1
| -0% | -$15 | ﹤0.01% | 2491 |
|
2023
Q4 | $180K | Buy |
10,555
+330
| +3% | +$5.64K | ﹤0.01% | 2457 |
|
2023
Q3 | $85.5K | Sell |
10,225
-45,032
| -81% | -$376K | ﹤0.01% | 2455 |
|
2023
Q2 | $1.37M | Sell |
55,257
-88,338
| -62% | -$2.19M | ﹤0.01% | 1642 |
|
2023
Q1 | $2.16M | Buy |
+143,595
| New | +$2.16M | ﹤0.01% | 1288 |
|
2022
Q1 | – | Sell |
-9,391
| Closed | -$327K | – | 2692 |
|
2021
Q4 | $327K | Sell |
9,391
-1,101
| -10% | -$38.3K | ﹤0.01% | 2368 |
|
2021
Q3 | $328K | Sell |
10,492
-693
| -6% | -$21.7K | ﹤0.01% | 2285 |
|
2021
Q2 | $434K | Buy |
11,185
+310
| +3% | +$12K | ﹤0.01% | 2181 |
|
2021
Q1 | $524K | Buy |
10,875
+566
| +5% | +$27.3K | ﹤0.01% | 2115 |
|
2020
Q4 | $536K | Buy |
10,309
+661
| +7% | +$34.4K | ﹤0.01% | 2034 |
|
2020
Q3 | $259K | Buy |
+9,648
| New | +$259K | ﹤0.01% | 2214 |
|